These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 2138051)

  • 1. The 24 h blood pressure responses of hypertensives to a once-a-day cilazapril regimen.
    Fernandez PG; Bolli P; Lee C
    Can J Cardiol; 1990 Mar; 6(2):53-8. PubMed ID: 2138051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cilazapril inhibits vascular responses to baroreflex-stimulated sympathetic neural activity in hypertensive patients.
    Fernandez PG; Bolli P; Lee C; Vasdev S
    Can J Cardiol; 1990; 6(1):9-14. PubMed ID: 2138049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive, enzymatic, and hormonal activity of cilazapril, a new angiotensin-converting enzyme inhibitor in patients with mild to moderate essential hypertension.
    Sánchez RA; Traballi CA; Barclay CA; Gilbert HB; Muscará M; Giannone C; Moledo LI
    J Cardiovasc Pharmacol; 1988 Feb; 11(2):230-4. PubMed ID: 2452319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeated administration of the converting enzyme inhibitor cilazapril to normal volunteers.
    Nussberger J; Fasanella d'Amore T; Porchet M; Waeber B; Brunner DB; Brunner HR; Kler L; Brown AN; Francis RJ
    J Cardiovasc Pharmacol; 1987 Jan; 9(1):39-44. PubMed ID: 2434792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive effects and pharmacokinetics of single and consecutive doses of cilazapril in hypertensive patients with normal and impaired renal function.
    Shionoiri H; Gotoh E; Takagi N; Takeda K; Yabana M; Kaneko Y
    J Cardiovasc Pharmacol; 1988 Feb; 11(2):242-9. PubMed ID: 2452321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discrepancies between clinic and ambulatory blood pressure responses to cilazapril therapy.
    Lacourcière Y; Leenen F; Rangno R; Spence JD; Lenis JH; Myers MG
    Can J Cardiol; 1994; 10(6):605-10. PubMed ID: 8044721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive effect of cilazapril in essential hypertensive patients. Clinical study with 24 h ambulatory blood pressure monitoring.
    Hiwatari M; Abe K; Yoshinaga K; Saito T
    Arzneimittelforschung; 1991 Nov; 41(11):1137-40. PubMed ID: 1839765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Placebo-controlled crossover comparison of spirapril at 3, 6, 12 and 24 mg once daily in mild to severe essential hypertension.
    Guitard C; Sassano P; Tzincoca C; Duchiez J; Safar ME
    Blood Press Suppl; 1994; 2():61-8. PubMed ID: 8061848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cilazapril, a new ACE inhibitor, in severe arterial hypertension].
    Arcila Herrera H; Montero Cervantes L; Rivero Cárdenas NA; Osorio Guerreo MI; Flores Serrano AG; González Franco MF
    Arch Inst Cardiol Mex; 1991; 61(6):573-8. PubMed ID: 1838916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacodynamic responses of hypertensive patients to quinapril therapy.
    Fernandez PG; Snedden W
    Can J Cardiol; 1992 Mar; 8(2):189-94. PubMed ID: 1559192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihypertensive treatment with cilazapril. Resting and exercise blood pressure, hormones and enzymes.
    Breithaupt K; Belz GG; Spielmanns DG; Neis W; Kirchner P
    Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):136-41. PubMed ID: 2159308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive efficacy of cilazapril 2.5 and 5.0 mg once-daily versus placebo on office blood pressure and 24-hour blood pressure profile.
    Prager G; Klein P; Schmitt M; Prager R
    J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S93-9. PubMed ID: 7700076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of single doses of the converting enzyme inhibitor cilazapril in normal volunteers.
    Fasanella d'Amore T; Bussien JP; Nussberger J; Waeber B; Turini GA; Brunner HR; Kler L; Francis RJ
    J Cardiovasc Pharmacol; 1987 Jan; 9(1):26-31. PubMed ID: 2434790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the effects of felodipine and cilazapril on exercise performance in patients with mild to moderate hypertension. A crossover study.
    Paterna S; Di Pasquale P; Parrinello G; Tuttolomondo A; Follone G; Cardinale A; Ortoleva A; Giambanco F; Abruzzese G; Colomba D; Bologna P; Fernández P; Giubilato A; Valdes L; Albano V; Licata G
    Drugs Exp Clin Res; 2000; 26(4):125-31. PubMed ID: 11109512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of cilazapril in patients with essential hypertension.
    Karpov YA; Vilchinskaya MY; Sorokin EV; Podinovskaya VA
    J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S86-8. PubMed ID: 7700074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacodynamics and dose-response relationships of the angiotensin converting enzyme inhibitor, cilazapril, in essential hypertension.
    Ajayi AA; Elliott HL; Reid JL
    Br J Clin Pharmacol; 1986 Aug; 22(2):167-75. PubMed ID: 3019375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cilazapril and nitrendipine on blood pressure, mood, sleep, and cognitive function in elderly hypertensive patients: an Italian multicenter study.
    Leonetti G; Salvetti A
    J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S73-7. PubMed ID: 7700071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative efficacy and safety of aliskiren, an oral direct renin inhibitor, and ramipril in hypertension: a 6-month, randomized, double-blind trial.
    Andersen K; Weinberger MH; Egan B; Constance CM; Ali MA; Jin J; Keefe DL
    J Hypertens; 2008 Mar; 26(3):589-99. PubMed ID: 18300872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors.
    McMahon FG; Weinstein SP; Rowe E; Ernst KR; Johnson F; Fujioka K;
    J Hum Hypertens; 2002 Jan; 16(1):5-11. PubMed ID: 11840224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of enalapril maleate on blood pressure, renin-angiotensin-aldosterone system, and peripheral sympathetic activity in essential hypertension.
    Cerasola G; Cottone S; D'Ignoto G; Grasso L; Carone MB; Carapelle E; Contorno A
    Clin Ther; 1987; 9(4):390-9. PubMed ID: 3038326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.